What is the probability of inheriting colon cancer

Medical research believes that colorectal cancer is a multi-gene genetic disease, and its occurrence is mainly related to environmental and genetic factors, but no one has counted the probability. The treatment of colorectal cancer is surgical resection of the tumor as the first choice, supplemented by radiotherapy, chemotherapy drugs and traditional Chinese medicine conservative treatment, etc. Surgery is only palliative resection or symptomatic treatment. After surgery, the body's vitality is damaged, and ginsenoside RH2 is generally used to assist in improving the success rate of surgery and reducing the recurrence and metastasis of tumors.

Chinese and Western medicine have their own strengths in treating tumors, so the treatment of colorectal cancer must give full play to the advantages of Chinese medicine, insist on long-term treatment, relax the patient's psychological state, do a good job of psychological treatment, increase dietary nutrition, and improve the patient's immune function. Only in this way can a better effect be achieved. About one-third to one-quarter of colorectal cancer cases are in the late stage. In addition, about 50% of the evaluations show recurrence and metastasis within 5 years after diagnosis.

The current radiotherapy and chemotherapy regimens are relatively mature and most of them are effective. Studies have shown that combining ginsenoside RH2 before, during, and after radiotherapy and chemotherapy can effectively enhance efficacy and reduce toxicity, shorten the recovery period, and prevent recurrence and metastasis. Existing literature supports the inhibitory effect of ginsenoside Rh2 on the growth of human colon cancer cell lines SW620 and LOVO. The current survival period of colorectal cancer is still relatively good. Prognosis requires more frequent review and attention to daily life patterns, especially dietary patterns.